TSE:MRV Nuvo Pharmaceuticals (MRV) Stock Price, News & Analysis → Top 5 AI Stocks to Buy for 2024 (From Market Moving Trends) (Ad) Free MRV Stock Alerts C$1.35 0.00 (0.00%) (As of 03/15/2023) Add Compare Share Share Today's RangeC$1.34▼C$1.3550-Day RangeC$1.35▼C$1.3552-Week RangeC$0.50▼C$1.55Volume6,730 shsAverage Volume27,569 shsMarket CapitalizationC$15.38 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get Nuvo Pharmaceuticals alerts: Email Address Ad Porter & CompanyHow Biden has already won 2024Obama’s Forever Term [Exposed] or Obama Biden has already won 2024 Exposed: the shocking election plot that will forever enshrine Obama’s destructive, Marxist vision for America… A plot that could hand him and his allies near-total control over the government, your way of life, and your future.Click here to watch this now before it’s too late. About Nuvo PharmaceuticalsNuvo Pharmaceuticals Inc., doing business as Miravo Healthcare, provides prescription and non-prescription products for pain, allergy, neurology, and dermatology worldwide. The company operates in three segments: Commercial Business, Production and Service Business, and Licensing and Royalty Business. It offers Blexten, an antihistamine drug for the symptomatic relief of allergic rhinitis and chronic spontaneous urticaria; Cambia, a nonsteroidal anti-inflammatory drug for migraine; Suvexx/Treximet, a migraine medicine; NeoVisc, an injectable viscosupplement for osteoarthritis; and Resultz, FullMarks, and LAUSBUB for head lice infestations. The company also provides Bezalip SR for patients with high cholesterol or high levels of triglycerides; Proferrin, an iron supplement for the prevention and treatment of iron deficiency; Fiorinal 1 and Fiorinal C1 for the relief of tension-type headaches; Collatamp G for surgical implantation during surgery; PegaLAX, a laxative for the treatment of occasional constipation and irregularity; Mutaflor, a probiotic for the management and relief of chronic constipation and associated abdominal pain and cramps; MoviPrep for the cleansing of the colon in preparation for colonoscopy; and Soriatane to treat psoriasis and other keratinization disorders. In addition, it offers Pennsaid and Pennsaid 2% topical treatments for osteoarthritic pain; Vimovo for relief of arthritis symptoms; SYNERA and RAPYDAN topical patches used to help prevent pain associated with needle sticks and other superficial skin procedures; Yosprala for the prevention of heart attacks and strokes; and Heated Lidocaine/Tetracaine Patch, a topical patch applied prior to painful medical procedures. The company was formerly known as Nuvo Research Inc. and changed its name to Nuvo Pharmaceuticals Inc. in March 2016. Nuvo Pharmaceuticals Inc. was incorporated in 1983 and is headquartered in Mississauga, Canada.Read More MRV Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart MRV Stock News HeadlinesMay 17, 2024 | finance.yahoo.comHoldco Nuvo Group D.G Ltd (NUVO)February 13, 2024 | wsj.comTaro Pharmaceutical Industries Ltd.January 30, 2024 | morningstar.comIonis Pharmaceuticals Inc IONSDecember 29, 2023 | uk.investing.comNuvoco Vistas Corporation Ltd (NUVO)November 22, 2023 | seekingalpha.comLIPO Lipella Pharmaceuticals Inc.April 17, 2023 | theglobeandmail.comClosing Bell: Nuvo Pharmaceuticals Inc flat on Wednesday (MRV)February 18, 2023 | benzinga.comPeak Pharmaceuticals Stock (OTC:PKPHD), DividendsFebruary 7, 2023 | finance.yahoo.comMiravo Healthcare™ Announces Filing of Special Meeting Materials in respect of Arrangement with Searchlight Pharma Inc.January 27, 2023 | seekingalpha.comMRV:CA Nuvo Pharmaceuticals Inc.December 23, 2022 | marketwatch.comNuvo Pharmaceuticals Agrees to be Acquired by Searchlight PharmaSee More Headlines Receive MRV Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Nuvo Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeTSE SectorMedical Industry Drug Manufacturers - Specialty & Generic Sub-IndustryN/A Current SymbolTSE:MRV CUSIPN/A CIKN/A Webwww.miravohealthcare.com PhoneN/AFaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)C($0.07) Trailing P/E RatioN/A Forward P/E Ratio19.61 P/E GrowthN/ANet IncomeC$15.17 million Net Margins20.95% Pretax MarginN/A Return on Equity1,180.47% Return on Assets5.85% Debt Debt-to-Equity Ratio1,165.85 Current Ratio2.11 Quick Ratio1.68 Sales & Book Value Annual SalesC$72.42 million Price / Sales0.21 Cash FlowC$5.98 per share Price / Cash Flow0.23 Book ValueC$0.75 per share Price / Book1.80Miscellaneous Outstanding Shares11,390,000Free FloatN/AMarket CapC$15.38 million OptionableNot Optionable Beta0.78 20 Stocks to Sell NowMarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.Get This Free Report Key ExecutivesMr. Jesse F. LedgerPres & CEOMs. Mary-Jane E. Burkett C.A.CPA, HBA, VP & CFODr. Bernard Joseph Chiasson Ph.D.VP of Operations & Chief Scientific OfficerMs. Katina K. Loucaides M.Sc.LL.B, VP, Corp. Sec. & Gen. CounselMr. Luigi BerardelliVP of Sales & MarketingKey CompetitorsMedexus PharmaceuticalsTSE:MDPViridium Pacific GroupCVE:VIRZomedica Pharmaceuticals Corp. (ZOM.V)CVE:ZOMCharlotte's WebTSE:CWEBInMed PharmaceuticalsTSE:INView All Competitors MRV Stock Analysis - Frequently Asked Questions How have MRV shares performed in 2024? Nuvo Pharmaceuticals' stock was trading at C$1.35 on January 1st, 2024. Since then, MRV stock has increased by 0.0% and is now trading at C$1.35. View the best growth stocks for 2024 here. How do I buy shares of Nuvo Pharmaceuticals? Shares of MRV stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.Compare Top Brokerages Here. This page (TSE:MRV) was last updated on 6/10/2024 by MarketBeat.com Staff From Our PartnersIt's time to ween off Chinese lithium!As the lithium rush continues, this small-cap NASDAQ-traded company may be one of the brightest and most promi...Smallcaps Daily | SponsoredTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | SponsoredTop 5 AI Stocks to Buy for 2024The electric vehicle boom is accelerating – and fast.Market Moving Trends | SponsoredNo Strings Attached: Get 30 Days of Hedgeye’s Top Stock Picks for FreeOptimize your stock investing strategy with Hedgeye's Investing Ideas, where rigorous fundamental stock analys...Hedgeye | SponsoredAI's Next Magnificent SevenThe Original Magnificent Seven Produced 16,894% Average Returns Over 20 Years.The Oxford Club | SponsoredThe Only Energy Play You Should Be Looking AtOpen AI’s Sam Altman recently helped this company raise $577 million in funding… What’s more is, It has alr...Wealthpin Pro | SponsoredYou won't believe what Citigroup just did to it's depositorsThe FEDNOW Biden Dollar ends cash in a matter of WEEKS Stumbling Biden's dollar next phases begins Oct 21st...American Alternative | SponsoredWrite this ticker symbol down…A megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made...StocksToTrade | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Nuvo Pharmaceuticals Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Nuvo Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.